Auteurs
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « Auteurs » - entrée « E. Tanaka »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
E. T. Koh < E. Tanaka < E. Tanaka-Kudo  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000438 (2013) E. Tanaka [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; A. Kobayashi [Japon] ; N. Sugimoto [Japon] ; K. Shidara [Japon] ; E. Sato [Japon] ; Y. Seto [Japon] ; A. Nakajima [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon]AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database
000555 (2013) Y. Maeda ; S. Ohshima ; M. Yoshimura ; A. Watanabe ; E. Tanaka ; S. Tsuji ; Y. Harada [Japon] ; M. Matsushita ; Y. Katada [Japon] ; J. Hashimoto ; Y. SaekiAB0589 Steroid-sparing effect of tocilizumab in the treatment of rheumatoid arthritis
000581 (2013) T. Takeuchi [Japon] ; Y. Tanaka ; K. Amano ; J. Kikuchi [Japon] ; E. Tanaka [Japon] ; S. Hirata ; H. Nagasawa ; H. Yasuoka [Japon] ; H. Yamanaka [Japon]SAT0140 Effectiveness of Abatacept Against Rheumatoid Arthritis in Daily Clinical Practice - Orbit Study
000772 (2013) E. Tanaka [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; K. Shidara [Japon] ; E. Sato [Japon] ; Y. Inoue [Japon] ; Y. Seto [Japon] ; A. Nakajima [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon]AB0308 Optimal timing for tocilizumab administration to patients with rheumatoid arthritis in japan based on a cost-effectiveness analysis using the iorra cohort study
000964 (2013) S. Tsuji ; A. Yura ; M. Katayama ; A. Watanabe ; S. Teshigawara ; M. Yoshimura ; E. Tanaka ; Y. Harada ; Y. Katada ; M. Matsushita ; S. Ohshima [Japon] ; J. Hashimoto ; Y. Saeki [Japon]SAT0135 Procalcitonin (PCT) Level as a Predictor Of Remission in Rheumatoid Arthritis (RA) Patients Receiving Tocilizumab (TCZ): A Single-Center Retrospective Study
000B47 (2013) M. Yoshimura ; Y. Maeda ; M. Katayama ; A. Watanabe ; E. Tanaka ; S. Tsuji ; Y. Harada ; Y. Katada ; M. Matsushita ; J. Hashimoto ; S. Ohshima [Japon] ; Y. Saeki [Japon]SAT0103 The analysis of reasons of discontinuing biologics in japanese patients with rheumatoid arthritis; from the ninja (national database of rheumatic disease by IR-net in japan)
000B86 (2013) Y. Shimizu [Japon] ; E. Tanaka [Japon] ; E. Inoue [Japon] ; K. Shidara [Japon] ; D. Hoshi [Japon] ; N. Sugimoto [Japon] ; E. Sato [Japon] ; Y. Seto [Japon] ; S. Momohara [Japon] ; A. Nakajima [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon]FRI0096 Influence of dose titration of concomitant steroid and methotrexate during biologic therapy on remission rates in patients with rheumatoid arthritis according to the new ACR/EULAR remission criteria in daily practice based on the iorra cohort
000C29 (2013) Y. Maeda ; M. Matsushita ; A. Yura ; S. Teshigawara ; M. Katayama ; M. Yoshimura ; A. Watanabe ; E. Tanaka ; S. Tsuji ; A. Kitatobe ; Y. Harada ; S. Ohshima ; Y. Katada ; J. Hashimoto ; K. Ogata [Japon] ; T. Takahashi [Japon] ; H. Tsuji [Japon] ; K. Nomoto [Japon] ; A. Kumanogoh ; K. Takeda ; Y. SaekiOP0191 The Fecal Microbiota of Rheumatoid Arthritis Patients Differs from that of Healthy Volunteers and is Considerably Altered by Treatment with Biologics
000D61 (2013) K. Ochi [Japon] ; E. Tanaka [Japon] ; K. Shidara [Japon] ; K. Ikari [Japon] ; A. Nakajima [Japon] ; A. Taniguchi [Japon] ; S. Momohara [Japon] ; H. Yamanaka [Japon]FRI0065 Clinical factors associated with the progression of functional impairment in rheumatoid arthritis patients who maintained the remission criteria defined by the new acr/eular criteria
000F04 (2013) K. Shidara [Japon] ; A. Nakajima [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; E. Tanaka [Japon] ; Y. Inoue [Japon] ; A. Kobayashi [Japon] ; Y. Seto [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon]FRI0068 Sustaining remission as defined by the new acr/eular criteria leads to better quality of life in patients with rheumatoid arthritis
000F98 (2013) Y. Maeda ; M. Matsushita ; M. Katayama ; M. Yoshimura ; A. Watanabe ; E. Tanaka ; S. Tsuji ; A. Kitatobe ; Y. Harada ; S. Ohshima ; Y. Katada ; J. Hashimoto ; Y. Saeki ; T. Takahashi [Japon] ; H. Tsuji [Japon] ; K. Nomoto [Japon] ; K. Takeda [Japon]SAT0079 The analysis of fecal microbiota in rheumatoid arthritis patients compared to healthy volunteers using bacterial RRNA-targeted reverse transcription-quantitative PCR

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/Author.i -k "E. Tanaka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/Author.i  \
                -Sk "E. Tanaka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    E. Tanaka
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021